Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients

AIMS: There is no evidence demonstrating the clinical usefulness of phosphodiesterase (PDE) inhibitors in the treatment of asthma, although PDE3 and 4 inhibitors have received much attention for the treatment of bronchial asthma. We compared the bronchodilator effects of intravenously administered o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Myou, Shigeharu, Fujimura, Masaki, Kamio, Yumie, Hirose, Tatsuki, Kita, Toshiyuki, Tachibana, Hideki, Ishiura, Yoshihisa, Watanabe, Kazuyoshi, Hashimoto, Takuma, Nakao, Shinji
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 2003
Sujets:
Pharmacodynamics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884231/
https://ncbi.nlm.nih.gov/pubmed/12680881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01760.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires